Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer
A phase 3 trial demonstrates multiple benefits of adding the androgen-receptor inhibitor darolutamide to standard therapy.
Prostate cancer is a malignant growth in the prostate (a sex gland in men found below the bladder and in front of the rectum).
Claire & John Bertucci
The Claire & John Bertucci Center for Genitourinary Cancers is one of the largest, most experienced centers in New England for the treatment and care of patients with bladder, kidney, prostate and other genitourinary cancers.
The Clinic for Reproductive Health and Cancer at Massachusetts General Hospital provides guidance on fertility preservation for cancer patients to help protect their future reproductive options.
Specialists in the Genitourinary Program in the Department of Radiation Oncology are renowned for their expertise in using advanced radiation therapies to treat cancers of the urinary tract (males and females) and the reproductive tract (males).
Helps to identify and provide comprehensive, coordinated medical care for families that have a hereditary predisposition to prostate cancer.
Experts in our program offer care for slow-growing and aggressive forms of prostate cancer.
The purpose of this study was to quantify and describe the amount of waste generated by an Emergency Department, identify deviations from waste policy and explore areas for waste reduction.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.